This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 03/09/2020
Location: Silver Spring, MD
Subject: FDA / Federal Trade Commissione (FTC) Workshop on a Competitive Marketplace for Biosimilars
FDA Participant/Group: Several FDA staff attended this event.
Non FDA Participant/Group: Representatives from industry, government, media and other registered guests

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 03/11/2020
Location: Virtual
Subject: CBD Policy Working Group Listening Session with Realm of Caring
FDA Participant/Group: LOWELL SCHILLER; CARA WELCH; MICHAEL LEVY; TYNA DAO; REBECCA GOLDBERG; SHARON MAYL; PATRICK COURNOYER; MELISSA ROBB; RACHEL OSTERMAN; EMILY ROSE CAREY; LINDA KATZ; APRIL ALEXANDROW; CASSANDRA TAYLOR; LOIS FREED; DENNIS KEEFE; SUPRATIM CHOUDHURI; NATALIE GETZOFF; JOSEPH FRANKLIN; YITONG LIU; ALISON THOMPSON;
Non FDA Participant/Group: Jonathan Hoggard (Realm of Caring); Ryan Vandrey (Johns Hopkins University);

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 03/11/2020
Location: Washington, D.C.
Subject: Speaker: FDA’s Efforts to Strengthen Regulatory Systems Abroad
FDA Participant/Group: SEMA HASHEMI, LAYLA BATARESH, RUSSELL CAMPBELL
Non FDA Participant/Group: Representatives of the National Acadamies of Sciences, Engineering, and Medicine

Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/10/2020
Location: Arlington, VA
Subject: America’s Blood Centers Annual Meeting; Keeping Pace with Change: The Perspective from FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of America’s Blood Centers

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 03/09/2020
Location: Rockville, MD
Subject: The Pew Charitable Trusts Quarterly Meeting
FDA Participant/Group: REGINA TAN; MATTHEW LUCIA; TIMOTHY SCHELL; NEAL BATALLER; PATRICK MCDERMOTT; CINDY BURNSTEEL; SIOBHAN DELANCEY; MARGARET OELLER; SUSAN BRIGHT-PONTE; ASHLEY STEEL; NADINE STEINBERG; WILLIAM FLYNN;
Non FDA Participant/Group: Representatives from The Pew Charitable Trusts

Event Date: 03/10/2020
Location: Telecon
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Represetatives from National Association of Dairy Regulatory Officials

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event